- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Prevention of pneumococcal disease
- Meeting Date: November 2021
- Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 1402KB)
- Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 462KB)
Pneumococcal polysaccharide conjugate vaccine, 15 valent adsorbed – November 2021
Pneumococcal Polysaccharide Conjugate Vaccine, 15 Valent Adsorbed: 0.5 mL in pre-filled syringe; Trade name TBC
Last updated
4 March 2022